Sorrento Therapeutics, Inc SRNE

astoinis

I think this has a range to stay within if its going to survive Ideally it will stay within the 86 to 70 cent region, any further break down and we are in no mans land. Even now we are in uncharted waters for this stock which has traditionally show much support and bounce at $1.45 Sub $1 can either be a steal or bad news bears. would DCA in this position and...

day0 Updated 

SRNE possible increase around 2022-01 and 2022-02. Then a possible decrease around Spring 2022.

Zivul33 Premium Updated 

The asset has hit an all-time Low currently taking back its old Load-zone and has the potential to achieve midline of its long-term channel. A breakout over R2 (minor resistance) can trigger a swing to the following targets.

Rykin_Capital Pro+ Updated 

Speculating end of A Wave, now in the beginning of an Elliott triangle or a variation of ABCDE pattern. Bearish. Early stage of pivot if real, as none of the volatility, parabolism, volume weight indicators have caught up yet. And it shows - I have not bothered to wait for confirmation. Agressive stance therfore. We are not in the business of getting every...

Chopstick_Charlie Premium Updated 

Sorrento therapeutics is a chart that interests me. Measured move from pennant hit exactly which explains the bounce but I am anticipating a move down to horizontal support at 1.50. Will go into more detail on the daily chart. RSI flashed into oversold conditions recently however no bullish divergence. High risk high reward however any buys in this area, in the...

Susan1979 Premium

Sec.gov Contingent Consideration We have contingent consideration obligations in connection with certain acquisition and licensing transactions that are contingent upon achieving certain specified milestones or the occurrence of certain events, including those described within the accompanying notes to the consolidated financial statements in Part I, Item 1 of...

kingav69 Updated 

I think this is a good place to start a position, if it breaks here next support zone is approx 3.75. High demand for tests currently a good PR from this company could send it north after a long bear trend. Good luck.

NRPICKS_ Premium Updated 

Sorrento Therapeutics, Inc. is a commercial and clinical-stage biopharmaceutical company developing therapies for cancer, autoimmune, inflammatory, viral and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex.

game_trader

Series of negative events and environment was dragging down the stock. Key resistance of 9.2 was not broken in August, taking it into downtrend. Yet, the fundamentally the company is undervalued and flies under radar. It will start grasping more attention as COVISTIX and G-MAB library products will continue progressing with approvals. In short term TA...

mrtnquint

Per chart analysis plotted last month, $SRNE has landed exactly at the upswing mark highlighted in the red oval. 3 point meet with resistance and support, also considering Recent PR of President Biden's demand for mandated vaccination. The Gann Square thus far has proven its success at predicting price movement. Good luck all.

mrtnquint

Following up from the prior post published, the Gann Square has continued proving its accuracy with traders. Here i highlight the plots layed out from weeks ago that has set prime levels for support and resistance. As seen, the upward trend is ready to move past resistance and into its next level as the stock tested $9.63 . A nice withdrawal from RSI will assist...

game_trader

I'm long in this stock and been studying it for quite a well. Strong pipeline and recent news on agreement with Texas A&M University System around one of it's development related to fighting Covid-19 by inhibiting MPro enzyme. The company also has several other programs to address Covid-19 as well as cancer, immunological diseases and pain. Technical set-up...

shkspr Premium

NASDAQ:SRNE Possible Scenario: LONG Evidence: Price Action, Break-out confirmed TP1: 11.30$ Call options 17th Sep, Strike 9$ is safest bet *This is my idea and could be wrong 100%.

marcavilavall Updated 

I think that in final of August SRNE start a new rallie, I hope that start early than I think. On the graph you can see my prediction lines : Red -> Resistance that if overcome will become support. Orange -> Our resistance lines that we try to broke, I think that will broke the bearish trend almost late Agust, September 1th and we take over the line of 9,5$...

goodguy Pro

My last post in January was wrong. Here is how it looks to me now. Often volume drops toward the end of the triangle. Personally I will take profits at "D". Process your way. Have a good week.

mrtnquint

Looking at the 6 month trend in Sorrento after its early year uptrend, the company has released back to back catalyst. However, FDA approval has been the majority in its probability to be valued. The gann square is showing no resistance as both horizontal lines since July have not crossed 50%, they are both currently within 12%, which states full support on its...

PennyStocks101

This could be an important area for SRNE right now. You've got Fibs and major moving averages all converging at the same point. News today: "Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a...

ChemGradTrades Pro+ Updated 

SRNE finished a deeper than expected 0.88 retracement to complete a wave 2 of a larger degree wave (3) around mid May and since then has had a nice impulse to the upside. From an Elliott Wave perspective, there is plenty of upside for SRNE to run. Currently waiting for a shallow pull-back to around $8.50-8.00 range before entering long. *Dates on chart don't...